Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter ART2.2/Art2b Antikörper

Art2b Reaktivität: Maus ICFC Wirt: Maus Monoclonal S-16a unconjugated single-domain Antibody (sdAb) Recombinant Antibody
Produktnummer ABIN2656684
  • Target Alle ART2.2/Art2b (Art2b) Produkte
    ART2.2/Art2b (Art2b) (ADP-Ribosyltransferase 2b (Art2b))
    Antikörpertyp
    Recombinant Antibody
    Fragment
    single-domain Antibody (sdAb)
    Reaktivität
    Maus
    Wirt
    • 3
    Maus
    Klonalität
    • 2
    Monoklonal
    Konjugat
    • 3
    Dieser ART2.2/Art2b Antikörper ist unkonjugiert
    Applikation
    • 3
    • 3
    Intracellular Flow Cytometry (ICFC)
    Marke
    Treg-Protector™
    Produktmerkmale
    ARTC2, also known as ART2.2, is a 35 kD, GPI-anchored, and cell surface ADP-ribosyltransferase that is highly expressed by regulatory T cells (Tregs) and natural killer T (NKT) cells. ARTC2 is enzymatically active at 4°C. Through the ribosylation of the ion channel P2X7, ARTC2 mediates NAD+-induced cell death (NICD) and the proteolytic shedding of CD27 and CD62L. Blocking the activity ARTC2 with Treg-Protector™ improves the recovery of Tregs and NKT cells during their isolation from lymphatic and peripheral tissues.
    Reinheit
    ≥ 95%, as determined by Coomassie stained SDS-PAGE.
    Endotoxin-Niveau
    Less than 0.01 ng of endotoxin/µg of protein, as determined by the LAL method.
    Immunogen
    Expression vector encoding full length mouse ARTC2.
    Klon
    S-16a
    Isotyp
    Ig Fraction
  • Applikationshinweise
    Treg-Protector™ (S+16a) is a recombinant llama VH Ig domain that binds to the ADP-ribosyltransferase ARTC2, which reversibly blocks its enzymatic activity and protects ARTC2+ cells from NAD+-induced cell death (NICD), which is caused by the release of NAD+ by cells that die during the preparation of primary lymphocytes. The S+16a has been demonstrated to protect a variety of cell types including Tregs, NKT cells, and tissue-resident memory T cells.
    Kommentare

    We recommend diluting Treg-Protector™ 1:4 with sterile PBS and administer 200 µL (50 µg) intravenously (i.v.) of diluted Treg-Protector™ per mouse. Euthanize the mouse and begin the cell preparation 15 - 60 minutes after the injection. Intraperitoneal (IP) injection is also effective at similar doses (validated by developer).

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    1 mg/mL S-16a in PBS Treg-Protector ™ is sterilized by filtration through a 0.22 μm membrane and contains no preservatives.
    Konservierungsmittel
    Without preservative
    Handhabung
    Do not freeze. Keep sterile.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store between 2°C and 8°C. Do not freeze. Keep sterile.
  • Target
    ART2.2/Art2b (Art2b) (ADP-Ribosyltransferase 2b (Art2b))
    Andere Bezeichnung
    ARTC2 Nanobody (Art2b Produkte)
    Gen-ID
    11872
Sie sind hier:
Kundenservice